Traditional Chinese Herbal Medicine (TCM) has made an important contribution to preventing and controlling Covid19 since the outbreaks began in 2020.
The NIH published a new study in PubMed Feb 28, 2022. The study explains how researchers systematically screened literature of various randomized controlled trials (RCT) of Traditionally Chinese herbs used for Cov id and what they found you will never hear about in legacy media.
After a Meta-analysis of 29 RCT’s involving 12,460 patients herbal treatments were found highly successful for both severe and critical patients. The study, (link below) found Chinese herb blends reduced the mortality rate of patients with severe Cov19 by 55%.
Chinese herbal medicine was also found to relieve clinical symptoms and curtail hospital stays, improve laboratory indicators and more.
In addition, within the randomized studies consulted, a large number of the Chinese herbs used for COVID19 had biological constituents which can bind to antiviral targets and down regulate inflammation and regulate the immune system.
Authors of the study will continue research into the components of these herbs and the mechanism of actions for Coronavirus diseases.
Find the study abstract here:: https://pubmed.ncbi.nlm.nih.gov/35227280/
Zhao Z, Li Y, Zhou L, et al. Prevention and treatment of COVID-19 using traditional Chinese medicine: a review. Phytomedicine. 2021;85:153308. – PubMed
An X, Zhang Y, Duan L, et al. The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19. Biomed Pharmacother. 2021;137:111267. – PubMed – PMC
An X, Duan L, Zhang YH, et al. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19. Chin Med. 2021;16:44. – PubMed – PMC
Liu M, Gao Y, Yuan Y, et al. Efficacy and safety of integrated traditional Chinese and western medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis. Pharmacol Res. 2020;158:104896. – PubMed – PMC
Xiong X, Wang P, Su K, et al. Chinese herbal medicine for coronavirus disease 2019: a systematic review and meta-analysis. Pharmacol Res. 2020;160:105056. – PubMed – PMC